Summary:
- Researchers at Columbia University have identified significant challenges in CRISPR-Cas9 gene editing within human embryos, specifically noting that the process can lead to unintended large-scale deletions and chromosomal rearrangements.
- The study highlights that while gene editing shows potential for correcting genetic mutations, the current lack of precision poses safety risks that must be addressed before clinical applications can be considered.